Introduction to The Future Of Targeted Radiopharmaceutical Therapy In Prostate Cancer
Let's dive into the details surrounding The Future Of Targeted Radiopharmaceutical Therapy In Prostate Cancer. In this special Ask the Expert episode, we welcome
The Future Of Targeted Radiopharmaceutical Therapy In Prostate Cancer Comprehensive Overview
David Wise, NYU Langone Health, New York, NY, discusses the evolving role of radioligands in Geoffrey Johnson, MD, PhD, Mayo Clinic, Rochester, MN, discusses the emerging role of Neil Bander & Michael Hofman discuss the
Dr. Phillip J. Koo, MD, discusses the use of
Summary & Highlights for The Future Of Targeted Radiopharmaceutical Therapy In Prostate Cancer
- Dr. E. David Crawford discussed
- Michael Morris, MD,
- 3.3 million American men live with
- Anthony Victor D'Amico, MD, PhD, Dana-Farber
- Scott T. Tagawa, MD, MS, FACP, Weill Cornell Medical College, New York, NY, reflects on the current clinical applications of ...
That wraps up our extensive overview of The Future Of Targeted Radiopharmaceutical Therapy In Prostate Cancer.
